Female Reproductive System Neoplasm — Trials

Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,174 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 601–650 of 1,429 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03691376	Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	terminated	Phase 1	4	Roswell Park Cancer InstituteOTHER	1	Sep 19, 2024	clinicaltrials
NCT05002868	Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors	completed	Phase 1	23	Rhizen Pharmaceuticals SAINDUSTRY	2	Sep 19, 2024